Serial Assessment of Depression and Anxiety by Patients and Providers in Women Receiving Chemotherapy for Early Breast Cancer

Patient‐reported and clinician‐reported chemotherapy‐induced peripheral neuropathy in patients with early breast cancer: Current clinical practice

(2019) Kirsten A. Nyrop et al.   CANCER

Longitudinal Trends in Anxiety, Depression, and Quality of Life During Different Intermittent Periods of Adjuvant Breast Cancer Chemotherapy

(2018) Jiayuan Zhang et al.   CANCER NURSING

Mental status evaluation in older adults with cancer: Development of the Mental Health Index-13

(2018) Mackenzi Pergolotti et al.   Journal of Geriatric Oncology

Patient‐Reported Toxicities During Chemotherapy Regimens in Current Clinical Practice for Early Breast Cancer

(2018) Kirsten A. Nyrop et al.   ONCOLOGIST

A prospective study of changes in anxiety, depression, and problems in living during chemotherapy treatments: effects of age and gender

(2017) Cristiane Decat Bergerot et al.   SUPPORTIVE CARE IN CANCER

Association between social support, functional status, and change in health-related quality of life and changes in anxiety and depression in colorectal cancer patients

(2016) M. Gonzalez-Saenz de Tejada et al.   PSYCHO-ONCOLOGY

Support for the efficacy of behavioural activation in treating anxiety in breast cancer patients

(2016) Derek R. Hopko et al.   Clinical Psychologist

Comparison of Patient- and Practitioner-Reported Toxic Effects Associated With Chemoradiotherapy for Head and Neck Cancer

(2016) Aaron D. Falchook et al.   JAMA Otolaryngology-Head & Neck Surgery

Self-evaluation of Adjuvant Chemotherapy-Related Adverse Effects by Patients With Breast Cancer

(2016) Filippo Montemurro et al.   JAMA Oncology

Validity and Reliability of the US National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

(2015) Amylou C. Dueck et al.   JAMA Oncology

Recommended Patient-Reported Core Set of Symptoms to Measure in Adult Cancer Treatment Trials

(2014) B. B. Reeve et al.   JNCI-Journal of the National Cancer Institute

Development of the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

(2014) E. Basch et al.   JNCI-Journal of the National Cancer Institute

Course of depression, mental health service utilization and treatment preferences in women receiving chemotherapy for breast cancer

(2013) Julia C. Reece et al.   GENERAL HOSPITAL PSYCHIATRY

Predictors of anxiety and depression in people with colorectal cancer

(2013) Nicola M. Gray et al.   SUPPORTIVE CARE IN CANCER

Comparison Between Patient-Reported and Clinician-Observed Symptoms in Oncology

(2012) Canhua Xiao et al.   CANCER NURSING

Anxiety and depression after cancer diagnosis: Prevalence rates by cancer type, gender, and age

(2012) Wolfgang Linden et al.   JOURNAL OF AFFECTIVE DISORDERS

Associations among musculoskeletal impairments, depression, body image and fatigue in breast cancer survivors within the first year after treatment

(2011) I. CANTARERO-VILLANUEVA et al.   EUROPEAN JOURNAL OF CANCER CARE

Depression as a predictor of disease progression and mortality in cancer patients

(2009) Jillian R. Satin et al.   CANCER

Anxiety, depression and quality of life among Chinese breast cancer patients during adjuvant therapy

(2009) Winnie K.W. So et al.   European Journal of Oncology Nursing

What do predict anxiety and depression in breast cancer patients? A follow-up study

(2009) Mariam Vahdaninia et al.   SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY

Major depression after breast cancer: a review of epidemiology and treatment

(2008) Jesse R. Fann et al.   GENERAL HOSPITAL PSYCHIATRY